View Single Post
Old 06-04-2016, 09:42 AM   #2
nancy dip
Senior Member
 
Join Date: Jun 2007
Posts: 49
Re: ASCO: breakthrough finding in her2+ breast cancer--preventing resistance to anti

Have just read a report saying herceptin recognises the Her2 receptor but does not kill off the cells. It renders them dormant and they can become active at any time. Feeling slightly panicky!! Can anyone comment?
__________________
Found lump myself 8 months after routine mammogram.
29/11/06-WLE and then re-excision to get clear margins.
Tumour was 1.2cms; Grade3; Er+ Pr+ HER2 3+++; SNB negative out of 9 nodes.
Chemo was Epirubicin every 3wks x4 then Xeloda (2wks on, 1wk off) for 4 cycles. ( I am part of the TACT2 trial.)
Rads x25
Arimidex for 5 yrs.
Hoping to start Herceptin within the next 2 weeks (we have to follow the HERA protocol to qualify for Herceptin in the U.K.) I worry about the delay in starting Herceptin!! Started 8/10/07
nancy dip is offline   Reply With Quote